Section Arrow
AMIX.NASDAQ
- Autonomix Medical Inc.
Quotes are at least 15-min delayed:2026/08/05 16:37 EDT
After Hours
Last
 11.23
-0.87 (-7.19%)
Bid
11.2
Ask
11.38
High 12.29 
Low 11.11 
Volume 128.52K 
Regular Hours (Closed)
Last
 12.1
-7.4 (-37.95%)
Day High 
18.69 
Prev. Close
19.5 
1-M High
24.68 
Volume 
14.06M 
Bid
11.2
Ask
11.38
Day Low
11.62 
Open
13.62 
1-M Low
2.44 
Market Cap 
10.59M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.07 
20-SMA 5.21 
50-SMA 6.74 
52-W High 32.55 
52-W Low 2.44 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-48.72/--
Enterprise Value
11.59M
Balance Sheet
Book Value Per Share
10.86
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BJDXBluejay Diagnostics Inc.1.24+0.24+24.00%-- 
After Hours 1.2197 -0.0203 -1.64%
BSXBoston Scientific Corp47.74-1.35-2.75%20.57PE
After Hours 48.85 +1.11 +2.33%
AMIXAutonomix Medical Inc.12.1-7.4-37.95%-- 
After Hours 11.23 -0.87 -7.19%
ADGMAdagio Medical Holdings Inc.0.739-0.061-7.63%-- 
After Hours 0.691 -0.048 -6.50%
PACBPacific Biosciences of California1.3-0.14-9.72%-- 
After Hours 1.2701 -0.0299 -2.30%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.